Compositions for labeling .beta.-amyloid plaques and neurofibrillary tangles
Abstract
Compositions useful for labeling .beta.-amyloid plaques and neurofibrillary tangles are provided. The compositions comprises compounds of formula (I): ##STR00001## wherein R.sub.1 is selected from the group consisting of --C(O)-alkyl, --C(O)-alkylenyl-R.sub.4, --C(O)O-alkyl, --C(O)O-alkylenyl-R.sub.4, --C.dbd.C(CN).sub.2-alkyl, --C.dbd.C(CN).sub.2-alkylenyl-R.sub.4, ##STR00002## wherein R.sub.4 is a radical selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; R.sub.5 is a radical selected from the group consisting of --NH.sub.2, --OH, --SH, --NH-alkyl, --NHR.sub.4, --NH-alkylenyl-R.sub.4, --O-alkyl, --O-alkylenyl-R.sub.4, --S-alkyl, and --S-alkylenyl-R.sub.4; R.sub.6 is a radical selected from the group consisting of --CN, --COOH, --C(O)O-alkyl, --C(O)O-alkylenyl-R.sub.4, --C(O)-alkyl, --C(O)-alkylenyl-R.sub.4, --C(O)-halogen, --C(O)NH-alkyl, --C(O)NH-alkylenyl-R.sub.4 and --C(O)NH.sub.2; R.sub.7 is a radical selected from the group consisting of O, NH, and S; and R.sub.8 is N, O or S; and R.sub.2 is selected from the group consisting of alkyl and alkylenyl-R.sub.10 and R.sub.3 is alkylenyl-R.sub.10, wherein R.sub.10 is selected from the group consisting of --OH, --OTs, halogen, spiperone, spiperone ketal, and spiperone-3-yl, or R.sub.2 and R.sub.3 together form a heterocyclic ring, optionally substituted with at least one radical selected from the group consisting of alkyl, alkoxy, OH, OTs, halogen, alkyl-R.sub.10, carbonyl, spiperone, spiperone ketal and spiperone-3-yl, and further wherein one or more of the hydrogen, halogen or carbon atoms are optionally replaced withmore »
- Inventors:
-
- Agoura Hills, CA
- Ljubljana, SI
- Los Angeles, CA
- Santa Monica, CA
- Sherman Oaks, CA
- Issue Date:
- Research Org.:
- Regents of University of California (Oakland, CA)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 970535
- Patent Number(s):
- 7341709
- Assignee:
- Regents of University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- DOE Contract Number:
- FC03-87ER60615
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Barrio, Jorge R, Petric, Andrej, Satyamurthy, Nagichettiar, Small, Gary W, Cole, Gregory M, and Huang, Sung-Cheng. Compositions for labeling .beta.-amyloid plaques and neurofibrillary tangles. United States: N. p., 2008.
Web.
Barrio, Jorge R, Petric, Andrej, Satyamurthy, Nagichettiar, Small, Gary W, Cole, Gregory M, & Huang, Sung-Cheng. Compositions for labeling .beta.-amyloid plaques and neurofibrillary tangles. United States.
Barrio, Jorge R, Petric, Andrej, Satyamurthy, Nagichettiar, Small, Gary W, Cole, Gregory M, and Huang, Sung-Cheng. Tue .
"Compositions for labeling .beta.-amyloid plaques and neurofibrillary tangles". United States. https://www.osti.gov/servlets/purl/970535.
@article{osti_970535,
title = {Compositions for labeling .beta.-amyloid plaques and neurofibrillary tangles},
author = {Barrio, Jorge R and Petric, Andrej and Satyamurthy, Nagichettiar and Small, Gary W and Cole, Gregory M and Huang, Sung-Cheng},
abstractNote = {Compositions useful for labeling .beta.-amyloid plaques and neurofibrillary tangles are provided. The compositions comprises compounds of formula (I): ##STR00001## wherein R.sub.1 is selected from the group consisting of --C(O)-alkyl, --C(O)-alkylenyl-R.sub.4, --C(O)O-alkyl, --C(O)O-alkylenyl-R.sub.4, --C.dbd.C(CN).sub.2-alkyl, --C.dbd.C(CN).sub.2-alkylenyl-R.sub.4, ##STR00002## wherein R.sub.4 is a radical selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; R.sub.5 is a radical selected from the group consisting of --NH.sub.2, --OH, --SH, --NH-alkyl, --NHR.sub.4, --NH-alkylenyl-R.sub.4, --O-alkyl, --O-alkylenyl-R.sub.4, --S-alkyl, and --S-alkylenyl-R.sub.4; R.sub.6 is a radical selected from the group consisting of --CN, --COOH, --C(O)O-alkyl, --C(O)O-alkylenyl-R.sub.4, --C(O)-alkyl, --C(O)-alkylenyl-R.sub.4, --C(O)-halogen, --C(O)NH-alkyl, --C(O)NH-alkylenyl-R.sub.4 and --C(O)NH.sub.2; R.sub.7 is a radical selected from the group consisting of O, NH, and S; and R.sub.8 is N, O or S; and R.sub.2 is selected from the group consisting of alkyl and alkylenyl-R.sub.10 and R.sub.3 is alkylenyl-R.sub.10, wherein R.sub.10 is selected from the group consisting of --OH, --OTs, halogen, spiperone, spiperone ketal, and spiperone-3-yl, or R.sub.2 and R.sub.3 together form a heterocyclic ring, optionally substituted with at least one radical selected from the group consisting of alkyl, alkoxy, OH, OTs, halogen, alkyl-R.sub.10, carbonyl, spiperone, spiperone ketal and spiperone-3-yl, and further wherein one or more of the hydrogen, halogen or carbon atoms are optionally replaced with a radiolabel.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2008},
month = {3}
}
Works referenced in this record:
1,1-Dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP): A Solvent Polarity and Viscosity Sensitive Fluorophore for Fluorescence Microscopy ⊥
journal, January 1996
- Jacobson, A.; Petric, A.; Hogenkamp, D.
- Journal of the American Chemical Society, Vol. 118, Issue 24
Preparation of99mTc-N2S2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease
journal, April 1999
- Dezutter, Nancy A.; de Groot, Tjibbe J.; Busson, Roger H.
- Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 42, Issue 4, p. 309-324
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease
journal, February 1996
- Mielke, R.; Schröder, R.; Fink, G. R.
- Acta Neuropathologica, Vol. 91, Issue 2
Application of PRODAN fluorescent probe to measure surface hydrophobicity of proteins interacting with κ-carrageenan
journal, May 2001
- Alizadeh-Pasdar, N.; Li-Chan, E. C. Y.
- Food Hydrocolloids, Vol. 15, Issue 3
Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches
journal, October 1986
- Huang, Sung-Cheng; Barrio, Jorge R.; Phelps, Michael E.
- Journal of Cerebral Blood Flow & Metabolism, Vol. 6, Issue 5
Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
journal, October 1995
- Saito, Y.; Buciak, J.; Yang, J.
- Proceedings of the National Academy of Sciences, Vol. 92, Issue 22
Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease
journal, November 1994
- Klunk, William E.; Debnath, Manik L.; Pettegrew, Jay W.
- Neurobiology of Aging, Vol. 15, Issue 6
Receptor Changes in the Neocortex of Post-Mortem Tissue in Parkinson's Disease and Alzheimer's Disease
journal, January 1992
- Griffiths, P. D.; Crossman, A. R.
- Dementia and Geriatric Cognitive Disorders, Vol. 3, Issue 4
Technetium Complexes for the Quantitation of Brain Amyloid
journal, January 1996
- Han, Hogyu; Cho, Cheon-Gyu; Lansbury, Peter T.
- Journal of the American Chemical Society, Vol. 118, Issue 18
The Preparation and Use of Radioiodinated Congo Red in Detecting Amyloidosis**Received August 21, 1959, from the Radioisotope Service, Veietatis Administration Center, Los Angeles, and the Departments of Radiology and Medicine, University of California Medical Center, Los Angeles, Calif.
journal, July 1960
- Tubis, Manuel; Blahd, William H.; Nordyke, Robert A.
- Journal of the American Pharmaceutical Association (Scientific ed.), Vol. 49, Issue 7
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography
journal, October 1997
- Imamura, Toru; Ishii, Kazunari; Sasaki, Masahiro
- Neuroscience Letters, Vol. 235, Issue 1-2
Tangles and plaques in nondemented aging and ?preclinical? Alzheimer's disease
journal, March 1999
- Price, Joseph L.; Morris, John C.
- Annals of Neurology, Vol. 45, Issue 3, p. 358-368
Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe
journal, August 1995
- Klunk, W.
- Neurobiology of Aging, Vol. 16, Issue 4
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.
journal, March 1995
- Merlini, G.; Ascari, E.; Amboldi, N.
- Proceedings of the National Academy of Sciences, Vol. 92, Issue 7
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
journal, March 1989
- Naiki, Hironobu; Higuchi, Keiichi; Hosokawa, Masanori
- Analytical Biochemistry, Vol. 177, Issue 2